Fibromatosis, Aggressive
|
0.700 |
CausalMutation
|
disease |
CGI |
|
|
|
Fibromatosis, Aggressive
|
0.700 |
SomaticCausalMutation
|
disease |
ORPHANET |
|
|
|
Fibromatosis, Aggressive
|
0.700 |
Biomarker
|
disease |
HPO |
|
|
|
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Aggressive fibromatosis is a mesenchymal neoplasm associated with mutations, resulting in beta-catenin-mediated transcriptional activation.
|
15674349 |
2005 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Aggressive fibromatosis is a mesenchymal neoplasm associated with mutations resulting in beta-catenin mediated transcriptional activation.
|
17160433 |
2007 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Aggressive fibromatosis (desmoid tumour) is a locally invasive tumour caused by mutations resulting in β-catenin protein stabilisation.
|
21468052 |
2011 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Aggressive fibromatosis (AF) is a rare fibroblastic proliferative disease with a locally aggressive behavior and no distant metastasis, characterized by driver mutations in CTNNB1 or the APC gene.
|
25174682 |
2014 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Desmoid type fibromatosis (DT) is a rare lesion of unclear pathogenesis that most often presents a mutation of the (β-catenin) gene.
|
26666421 |
2016 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Desmoid-type fibromatosis is characterized by CTNNB1 exon 3 mutations, which result in aberrant nuclear β-catenin localization and dysregulated canonical Wnt signaling.
|
27259010 |
2016 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
CTNNB1 mutations were observed in 117 of 138 (85%) of desmoids.
|
18832571 |
2008 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
LHGDN |
CTNNB1 mutations were observed in 117 of 138 (85%) of desmoids.
|
18832571 |
2008 |
Fibromatosis, Aggressive
|
0.700 |
Biomarker
|
disease |
BEFREE |
CTNNB1 genotyping can be very useful in 'difficult to diagnose' lesions when the differential diagnosis includes DT.
|
21884214 |
2011 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
CTNNB1 mutations were observed in 29 of 44 (66%) desmoids, with 3 mutations identified: T41A (64%), S45F (29%), and S45P (7%).
|
22372443 |
2013 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
CTNNB1 mutations were observed in 223 of 254 (88%) of sporadic desmoid tumors.
|
22766794 |
2012 |
Fibromatosis, Aggressive
|
0.700 |
Biomarker
|
disease |
BEFREE |
β-Catenin-negative desmoids either carried a CTNNB1 mutation or were associated with Gardner syndrome.
|
23020601 |
2013 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation study.
|
23913621 |
2013 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
CTNNB1 mutations are indeed common in sporadic desmoid tumors.
|
23960186 |
2013 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
CTNNB1 mutations associated to miRNA dysregulation could affect the genesis and the progression of this disease and help histological diagnosis of sporadic DTs.
|
28418912 |
2017 |
Fibromatosis, Aggressive
|
0.700 |
Biomarker
|
disease |
BEFREE |
β-Catenin, the genetic key player of desmoid tumors shows nuclear accumulation due to mutations that prevent its degradation leading to activation of Wnt signaling and myofibroblastic cell proliferation.
|
29705714 |
2018 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
A novel case of a sporadic desmoid tumour with mutation of the beta catenin gene.
|
10655994 |
1999 |
Fibromatosis, Aggressive
|
0.700 |
Biomarker
|
disease |
BEFREE |
Abnormalities of β-catenin and VEGF overexpression play an important role in the neoplastic progression of sporadic desmoid tumours.
|
22034877 |
2011 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Accumulation of altered beta-catenin associated with a somatic heterozygous activating mutation in codon 41 was detected in the typical desmoid-type fibromatosis and at the ossifying focus.
|
16007344 |
2005 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Additionally, we expanded the spectrum of mutations in CTNNB1 with one novel desmoid mutation.
|
24206198 |
2014 |
Fibromatosis, Aggressive
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin-regulatory function in aggressive fibromatosis (desmoid tumor).
|
9736021 |
1998 |
Fibromatosis, Aggressive
|
0.700 |
Biomarker
|
disease |
BEFREE |
All 15 desmoid tumors were positive for β-catenin (surrogate marker of Wnt/β-catenin pathway dysregulation) which was negative in control normal skin and scar samples.
|
26894649 |
2017 |